Abera Bioscience AB reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was SEK 1.19 million compared to SEK 0.816 million a year ago. Net loss was SEK 9.17 million compared to SEK 3.64 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 SEK | -1.26% | -1.67% | -8.72% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.72% | 6.58M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- ABERA Stock
- News Abera Bioscience AB
- Abera Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2021